PortfoliosLab logoPortfoliosLab logo
HCAT vs. AVAH
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

HCAT vs. AVAH - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Health Catalyst, Inc. (HCAT) and Aveanna Healthcare Holdings Inc. (AVAH). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, HCAT achieves a -4.18% return, which is significantly lower than AVAH's 18.36% return.


HCAT

1D
0.00%
1M
23.78%
6M
-6.91%
YTD
-4.18%
1Y
-41.13%
3Y*
-42.90%
5Y*
-47.02%
10Y*

AVAH

1D
-0.31%
1M
36.39%
6M
10.39%
YTD
18.36%
1Y
138.18%
3Y*
83.70%
5Y*
-2.77%
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

HCAT vs. AVAH - Yearly Performance Comparison


2026 (YTD)20252024202320222021
HCAT
Health Catalyst, Inc.
-4.18%-66.20%-23.65%-12.89%-73.17%-29.78%
AVAH
Aveanna Healthcare Holdings Inc.
18.36%78.77%70.52%243.59%-89.46%-38.33%

Correlation

The correlation between HCAT and AVAH is 0.24, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.24

Correlation (3Y)
Calculated over the trailing 3-year period

0.30

Correlation (5Y)
Calculated over the trailing 5-year period

0.29

Correlation (All Time)
Calculated using the full available price history since Apr 28, 2021

0.29

Fundamentals

Market Cap

HCAT:

$169.22M

AVAH:

$2.11B

EPS

HCAT:

-$3.72

AVAH:

$1.19

PS Ratio

HCAT:

0.54

AVAH:

0.84

PB Ratio

HCAT:

1.20

AVAH:

8.95

Total Revenue (TTM)

HCAT:

$302.48M

AVAH:

$2.52B

Gross Profit (TTM)

HCAT:

$103.36M

AVAH:

$823.98M

EBITDA (TTM)

HCAT:

-$85.17M

AVAH:

$306.37M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

HCAT vs. AVAH — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

HCAT
HCAT Risk / Return Rank: 2727
Overall Rank
HCAT Sharpe Ratio Rank: 2424
Sharpe Ratio Rank
HCAT Sortino Ratio Rank: 2929
Sortino Ratio Rank
HCAT Omega Ratio Rank: 2929
Omega Ratio Rank
HCAT Calmar Ratio Rank: 2525
Calmar Ratio Rank
HCAT Martin Ratio Rank: 2727
Martin Ratio Rank

AVAH
AVAH Risk / Return Rank: 9191
Overall Rank
AVAH Sharpe Ratio Rank: 9292
Sharpe Ratio Rank
AVAH Sortino Ratio Rank: 9595
Sortino Ratio Rank
AVAH Omega Ratio Rank: 9494
Omega Ratio Rank
AVAH Calmar Ratio Rank: 8989
Calmar Ratio Rank
AVAH Martin Ratio Rank: 8484
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

HCAT vs. AVAH - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Health Catalyst, Inc. (HCAT) and Aveanna Healthcare Holdings Inc. (AVAH). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


HCATAVAHDifference
Sharpe ratioReturn per unit of total volatility

-2.54

Sortino ratioReturn per unit of downside risk

-3.85

Omega ratioGain probability vs. loss probability

0.97

1.45

-0.48

Calmar ratioReturn relative to maximum drawdown

-0.55

3.52

-4.07

Martin ratioReturn relative to average drawdown

-0.87

6.51

-7.39

HCAT vs. AVAH - Sharpe Ratio Comparison

The current HCAT Sharpe Ratio is -0.45, which is lower than the AVAH Sharpe Ratio of 2.09. The chart below compares the historical Sharpe Ratios of HCAT and AVAH, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

HCAT vs. AVAH - Drawdown Comparison

The maximum HCAT drawdown since its inception was -98.30%, roughly equal to the maximum AVAH drawdown of -94.76%. Use the drawdown chart below to compare losses from any high point for HCAT and AVAH.


Loading charts...

Drawdown Indicators


HCATAVAHDifference

Max Drawdown

Largest peak-to-trough decline

-98.30%

-94.76%

-3.54%

Max Drawdown (1Y)

Largest decline over 1 year

-75.64%

-39.44%

-36.20%

Max Drawdown (3Y)

Largest decline over 3 years

-93.04%

-40.76%

-52.28%

Max Drawdown (5Y)

Largest decline over 5 years

-98.28%

-93.90%

-4.38%

Current Drawdown

Current decline from peak

-96.09%

-24.98%

-71.11%

Average Drawdown

Average peak-to-trough decline

-62.92%

-63.12%

+0.20%

Ulcer Index

Depth and duration of drawdowns from previous peaks

47.24%

21.30%

+25.94%

Volatility

HCAT vs. AVAH - Volatility Comparison

Health Catalyst, Inc. (HCAT) has a higher volatility of 18.15% compared to Aveanna Healthcare Holdings Inc. (AVAH) at 7.77%. This indicates that HCAT's price experiences larger fluctuations and is considered to be riskier than AVAH based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


HCATAVAHDifference

Volatility (1M)

Calculated over the trailing 1-month period

18.15%

7.77%

+10.38%

Volatility (6M)

Calculated over the trailing 6-month period

72.39%

32.74%

+39.65%

Volatility (1Y)

Calculated over the trailing 1-year period

91.78%

66.55%

+25.23%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

71.78%

78.29%

-6.51%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

67.94%

76.99%

-9.05%

Dividends

HCAT vs. AVAH - Dividend Comparison

Neither HCAT nor AVAH has paid dividends to shareholders.


Tickers have no history of dividend payments

Financials

HCAT vs. AVAH - Financials Comparison

This section allows you to compare key financial metrics between Health Catalyst, Inc. and Aveanna Healthcare Holdings Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


100.00M200.00M300.00M400.00M500.00M600.00M700.00MJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober2026April
70.76M
647.92M
(HCAT) Total Revenue
(AVAH) Total Revenue
Values in USD except per share items

Frequently Asked Questions


HCAT and AVAH have a correlation of 0.24, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

HCAT has higher volatility (18.15%) compared to AVAH (7.77%). In terms of maximum drawdown, HCAT dropped -98.30% vs AVAH's -94.76%.

AVAH currently has the higher Sharpe Ratio (2.09 vs -0.45), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for HCAT and AVAH

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer